ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

SECONAL SODIUM
Anxiety/OCD
Sleep-wake disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

SECONAL SODIUM CII

Generic Name and Formulations:
Secobarbital sodium 50mg, 100mg; caps.

Company:
Bausch Health Companies Inc.

Therapeutic Use:

Indications for SECONAL SODIUM:

For use as a preanesthetic sedative.

Adult:

200–300mg 1–2 hours before surgery. Elderly, debilitated, hepatic or renal impairment: reduce dose.

Children:

2–6mg/kg before surgery. Max 100mg.

Contraindications:

Manifest or latent porphyria. Marked hepatic impairment. Respiratory disease in which dyspnea or obstruction evident.

Warnings/Precautions:

Premonitory signs of hepatic coma: not recommended. Renal or hepatic impairment. Acute or chronic pain. Depression. Suicidal tendencies. Drug or alcohol abuse. Monitor hematopoietic, renal, hepatic systems with long-term therapy. Avoid abrupt cessation. Write ℞ for smallest practical amount. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat. D); may cause fetal damage. Nursing mothers.

Pharmacological Class:

Barbiturate.

Interactions:

Avoid concomitant griseofulvin. May antagonize oral anticoagulants (eg, warfarin), corticosteroids (may require dosage adjustments), doxycycline (monitor), oral contraceptives (consider alternative contraceptive method). May be potentiated by sodium valproate, valproic acid, MAOIs. Additive CNS depressant effects with alcohol, other CNS depressants. Concomitant phenytoin: monitor blood levels frequently.

Adverse Reactions:

Somnolence, agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, sleep-driving, hallucination, insomnia, anxiety, dizziness, abnormal thinking, hypoventilation, apnea, bradycardia, hypotension, syncope, GI upset, constipation, headache, hypersensitivity reactions, fever, liver damage.

How Supplied:

Caps—100


Data provided by MPR.

Indications for SECONAL SODIUM:

For short-term (2 weeks) treatment of insomnia.

Adult:

100mg at bedtime. Limit use to 2 weeks. Elderly, debilitated, hepatic or renal impairment: reduce dose.

Children:

Not recommended.

Contraindications:

Manifest or latent porphyria. Marked hepatic impairment. Respiratory disease in which dyspnea or obstruction evident.

Warnings/Precautions:

Premonitory signs of hepatic coma: not recommended. Renal or hepatic impairment. Acute or chronic pain. Depression. Suicidal tendencies. Drug or alcohol abuse. Monitor hematopoietic, renal, hepatic systems with long-term therapy. Avoid abrupt cessation. Write ℞ for smallest practical amount. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat. D); may cause fetal damage. Nursing mothers.

Pharmacological Class:

Barbiturate.

Interactions:

Avoid concomitant griseofulvin. May antagonize oral anticoagulants (eg, warfarin), corticosteroids (may require dosage adjustments), doxycycline (monitor), oral contraceptives (consider alternative contraceptive method). May be potentiated by sodium valproate, valproic acid, MAOIs. Additive CNS depressant effects with alcohol, other CNS depressants. Concomitant phenytoin: monitor blood levels frequently.

Adverse Reactions:

Somnolence, agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, sleep-driving, hallucination, insomnia, anxiety, dizziness, abnormal thinking, hypoventilation, apnea, bradycardia, hypotension, syncope, GI upset, constipation, headache, hypersensitivity reactions, fever, liver damage.

How Supplied:

Caps—100


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs